🏢 𝗡𝗲𝘄𝘀 ✨ 𝗟𝗕𝗜𝗖: 𝗔𝗽𝗲𝘅 𝗦𝘂𝗿𝗽𝗮𝘀𝘀𝗲𝘀 𝟱𝟬% 𝗢𝗰𝗰𝘂𝗽𝗮𝗻𝗰𝘆
We’re delighted to welcome Bind Research and twig bio to our growing community at the Apex building in King’s Cross, bringing LBIC’s space to over 50% occupancy just six months after launch.
Dr Rich Ferrie PhD RTTP, LBIC CEO, said:
"These two exciting companies will be key members of our community, benefiting from a culture of knowledge sharing and collaboration. Looking ahead, we will continue attracting companies at the intersection of bioscience and AI research, enhancing our community and creating a place where people feel welcome, and companies accelerate their growth.”
Bind Research, the UK’s first not-for-profit Focused Research Organisation (FRO), was established with £12.9 million from the UK Government’s Research Ventures Catalyst programme, matched by industry, philanthropic, and charitable partners, securing a total of £25.8 million in funding.
Gabriella Heller, CEO and Co-Founder, Bind Research, said:
"We’re excited to be joining the vibrant LBIC community at the Apex. This space offers the flexibility and infrastructure we need to build a world-class not-for-profit research organisation, and it’s crucial to be embedded in an environment that fosters collaboration, innovation, and scientific excellence.”
Gogulan Karunanithy, Director of Magnetic Resonance and Co-Founder, Bind Research, added:
"The Apex facility allows us to rapidly build a state-of-the-art laboratory in the heart of London’s dynamic life sciences sector. Its advanced infrastructure supports our specialised equipment and positions us to attract top talent, forge key partnerships, and drive progress toward treatments for currently untreatable diseases."
Joining LBIC from just around the corner, Russ Tucker, CEO & Co-Founder of twig bio, a next-generation sustainable ingredients biotech, commented:
"The Apex is conveniently close to our old site, maintaining access to top AI and science talent, supported by LBIC’s expert team, who know exactly what to prioritise for life science companies.”
📎 Read the full press release in the comments.
#LBICApex #LifeSciences #LabSpaceLondon